Tag: Fda drug shortages

As of September 2024, the United States saw a decrease in active drug shortages to 277, though half of these had persisted for two years or more. These prolonged and often critical supply disruptions mean that many patients are still at risk, raising concerns about what are the 5 essential drugs facing shortages and how the problem can be addressed.

According to a May 2025 report from the U.S. Pharmacopeia (USP), persistent, long-lasting shortages account for over 90% of all medication shortages in the United States, with the average duration now exceeding four years. Understanding **what medications are in shortage right now** is crucial for patients, healthcare providers, and the wider industry to mitigate the clinical and financial impacts of these supply chain disruptions.